日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma

细胞起源亚型可预测大B细胞淋巴瘤对波拉妥珠单抗的反应

Cliff, Edward R Scheffer; Pelaez, Guido D; Wan, Fei; Iyengar, Varun; Zhou, Jihao; Chung, Kevin; Abdel-Razeq, Nayef; Allen, Jessica; Major, Ajay; Sharp, John; Epperla, Narendranath; Gould, Patrick; Cherng, Hua-Jay J; Houshyar, Samin; Wallace, Danielle S; Lynch, Ryan C; Kallam, Avyakta; Mei, Matthew G; Merryman, Reid W; Fleyshman, Michelle; Rhodes, Joanna M; Kidwell, Adam; Fenske, Timothy S; Malakhov, Nikita; Mulvey, Erin; Watkins, Marcus P; Alhaj Moustafa, Muhamad; Hilal, Talal; Nowakowski, Grzegorz S; Wang, Yucai; Torka, Pallawi; Russler-Germain, David A

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials

优化肿瘤药物研发:对22年多发性骨髓瘤随机对照试验的系统评价

Mainou, Maria; Alsadhan, Muatassem; Tsapa, Kalliopi; Visram, Alissa; Mian, Hira; Popat, Rakesh; Mai, Elias K; Chakraborty, Rajshekhar; Al Hadidi, Samer; Mohan, Meera; Szabo, Aniko; Van Oekelen, Oliver; Cliff, Edward R Scheffer; Mohyuddin, Ghulam Rehman

Regulatory and Clinical Outcomes of Nononcology Accelerated Approvals

非肿瘤药物加速审批的监管和临床结果

Liu, Ian T T; Reynolds, Gemma; Kesselheim, Aaron S; Cliff, Edward R Scheffer

Changes in Oncology Medication Use After Withdrawal of Accelerated Approval

加速审批撤销后肿瘤药物使用情况的变化

Hwang, Catherine S; Kesselheim, Aaron S; Kelkar, Amar H; Cliff, Edward R Scheffer; Rome, Benjamin N

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

双特异性抗体治疗非复发死亡率:淋巴瘤和多发性骨髓瘤的系统评价和荟萃分析

Tix, Tobias; Alhomoud, Mohammad; Shouval, Roni; Iacoboni, Gloria; Cliff, Edward R Scheffer; Hansen, Doris K; Usmani, Saad Z; Salles, Gilles; Perales, Miguel-Angel; Cordas Dos Santos, David M; Rejeski, Kai

Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study

预测抗癌药物加速批准适应症撤回的因素:一项回顾性队列研究

Tibau, Ariadna; Cliff, Edward R Scheffer; Romano, Alejandra; Borrell, Maria; Molto, Consolacion; Kesselheim, Aaron S

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review

评估早期干预在冒烟型多发性骨髓瘤临床试验中的应用:系统评价

Kakkilaya, Apoorva; Trando, Aaron; Cliff, Edward R Scheffer; Mian, Hira; Al Hadidi, Samer; Aziz, Muhammad; Goodman, Aaron M; Jeong, Ah-Reum; Smith, Wade L; Kelkar, Amar H; Russler-Germain, David A; Mehra, Nikita; Chakraborty, Rajshekhar; Gertz, Morie A; Mohyuddin, Ghulam Rehman

Medicare spending and use of subcutaneous biologic formulations with hyaluronidase

医疗保险支出及皮下注射含透明质酸酶的生物制剂的使用情况

Kim, John; Kesselheim, Aaron S; Cliff, Edward R Scheffer; Rome, Benjamin N

Financial challenges of being on long-term, high-cost medications

长期服用高价药物带来的经济挑战

Elshiekh, Cleopatra; Rudà, Roberta; Cliff, Edward R Scheffer; Gany, Francesca; Budhu, Joshua A

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval

获得加速批准的癌症药物的临床获益和监管结果

Liu, Ian T T; Kesselheim, Aaron S; Cliff, Edward R Scheffer